Author: Site Editor Publish Time: 08-03-2026 Origin: Site
Can you have polynucleotides and Profhilo together? The answer is yes.
In regenerative aesthetics, polynucleotides and Profhilo represent two complementary approaches to improving skin quality. Polynucleotides focus on skin repair and regeneration, while Profhilo works mainly through hydration, collagen stimulation, and tissue remodeling.
For aesthetic clinics, combining these treatments is not simply about adding two products. The key is creating a protocol based on the patient’s skin condition, treatment areas, and desired outcomes.
Polynucleotides (PN) are purified DNA fragments extracted from salmon or trout sperm and used as regenerative injectable materials. PN does not add volume but supports the skin’s natural repair process.
After injection, PN helps improve the extracellular matrix environment, support fibroblast activity, and regulate inflammatory responses. Clinically, it is commonly used for concerns such as fine lines, reduced elasticity, and dull skin, especially in delicate areas like the periocular region and neck.
The key differences between PN products are mainly related to purity and molecular weight characteristics. PNPure™ is a well-recognized high-purity polynucleotide solution in regenerative aesthetics, developed with advanced PUNEXT™ purification technology. It features ≥99% PN purity and high molecular weight polynucleotides (1260–1570 kDa), designed for professional aesthetic applications.
Profhilo is a high-concentration stabilized hyaluronic acid (HA) injectable containing 64mg of HA per 2ml. It is designed for skin remodeling.
Using its proprietary NAHYCO® thermal hybrid technology, Profhilo spreads evenly within tissues and supports fibroblast activity to stimulate collagen and elastin production.
It is commonly selected for patients with skin laxity, dehydration, and reduced firmness in areas such as the face, neck, and hands.
Polynucleotides and Profhilo work through different biological pathways. PN consists of purified salmon DNA fragments, while Profhilo is based on hyaluronic acid, a substance naturally found in human skin. PN does not participate in human gene coding, and the two materials have different metabolic pathways, with no fundamental conflict when used together.
In clinical practice, combination protocols usually follow two approaches:
PN is more fluid and suitable for delicate areas such as the periocular region and neck. Profhilo helps improve skin laxity through tissue remodeling and is commonly used in areas such as the cheeks and jawline.
Some clinics may begin with PN sessions to improve overall skin quality, followed by Profhilo after a suitable interval. The order can also be reversed depending on whether the patient’s main concern is skin quality improvement or tissue firmness.
The best approach depends on the patient’s skin condition, treatment area, and clinical objectives.
The goal of combining polynucleotides and Profhilo is gradual improvement in overall skin quality.
Potential benefits include:
Improved skin texture: smoother and more refined skin appearance.
Enhanced firmness: better elasticity and skin resilience.
Increased hydration: improved moisture balance and radiance.
Long-term maintenance: Clinical experience suggests that combination treatment can support longer-lasting improvements by enhancing collagen remodeling.
Maintenance plans should be tailored according to individual skin condition, treatment response, and long-term aesthetic goals.
Many clinics prefer a structured approach rather than combining both products immediately at the first visit. Options may include completing PN sessions first and introducing Profhilo afterward, or using Profhilo initially and adding PN for targeted areas such as the periocular region.
This combination is often considered for patients with early to moderate signs of skin aging, including fine lines, reduced elasticity, dehydration, and loss of skin quality, especially when significant volume correction is not the primary goal.
Temporary injection bumps may occur after treatment and usually resolve within a short period. Patients should avoid makeup, intense exercise, and excessive heat exposure for approximately 24 hours after treatment.
Because combination protocols involve multiple sessions, clinics should clearly communicate the treatment timeline and set realistic expectations for gradual improvement.
The combination of polynucleotides and Profhilo offers a complementary approach within regenerative aesthetics.
For aesthetic clinics, this combination can provide more personalized treatment strategies beyond relying on a single injectable product. However, each protocol should be based on careful assessment of skin condition, aging concerns, and patient expectations.
A well-designed treatment plan, combined with appropriate product selection and aftercare guidance, is essential for achieving natural and consistent skin quality improvements.
